Cargando…

A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery

BACKGROUND AND AIMS: A popliteal block is effective in managing postoperative pain for foot surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa block technique, methods to prolong effective postoperative analgesia are mandatory. The aim of this study was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeylen, Kris, De Puydt, Joris, Engelen, Stefan, Roofthooft, Eva, Soetens, Filiep, Neyrinck, Arne, Van de Velde, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863693/
https://www.ncbi.nlm.nih.gov/pubmed/27226733
http://dx.doi.org/10.2147/LRA.S96073
_version_ 1782431518663114752
author Vermeylen, Kris
De Puydt, Joris
Engelen, Stefan
Roofthooft, Eva
Soetens, Filiep
Neyrinck, Arne
Van de Velde, Marc
author_facet Vermeylen, Kris
De Puydt, Joris
Engelen, Stefan
Roofthooft, Eva
Soetens, Filiep
Neyrinck, Arne
Van de Velde, Marc
author_sort Vermeylen, Kris
collection PubMed
description BACKGROUND AND AIMS: A popliteal block is effective in managing postoperative pain for foot surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa block technique, methods to prolong effective postoperative analgesia are mandatory. The aim of this study was to assess the effect of adjuvants to ropivacaine on the duration of sensory and motor block. METHODS: In this double-blind randomized placebo-controlled study, we evaluated the analgesic effect of clonidine or dexamethasone (DXM) when added to ropivacaine for hallux valgus surgery. After obtaining institutional ethics research board approval and written informed consent, a total of 72 patients were randomly allocated. Fifty-seven of these patients were statistically analyzed. All patients received an ultrasound-guided single-shot popliteal fossa block with 30 mL of ropivacaine 0.75%, supplemented with saline, clonidine 100 µg, or DXM 5 mg. The primary end point was time to first pain sensation. Secondary end points were time to complete sensory and motor block regression. RESULTS: Compared to saline, duration to first pain sensation was prolonged by 9 hours (mean ± standard deviation: 31±9 hours) (42%) in the DXM group (P=0.024) and by 6 hours (28±10 hours) (27%) in the clonidine group (P=0.024). Compared to saline, DXM prolonged both complete sensory and motor blockade by 12 hours (25±7 hours) (46%) and 13 hours (36±6 hours) (55%), respectively, while clonidine prolonged complete sensory and motor blockade by 7 hours (30±7 hours) (27%) and 2 hours (22±5 hours) (10%), respectively. DXM prolonged sensory block regression time by 6 hours (21±7 hours) (41%) and clonidine by 2 hours (17±6 hours) (13%) compared to the control group (P=0.006). Similarly, DXM prolonged motor block regression by 7 hours (25±7 hours) (46%) and clonidine by 4 hours (21±4 hours) (19%) (P<0.0001). CONCLUSION: Addition of DXM and clonidine to ropivacaine significantly prolonged the duration of postoperative sensory and motor block.
format Online
Article
Text
id pubmed-4863693
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-48636932016-05-25 A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery Vermeylen, Kris De Puydt, Joris Engelen, Stefan Roofthooft, Eva Soetens, Filiep Neyrinck, Arne Van de Velde, Marc Local Reg Anesth Original Research BACKGROUND AND AIMS: A popliteal block is effective in managing postoperative pain for foot surgery, but since the duration of analgesia is limited following a single-shot popliteal fossa block technique, methods to prolong effective postoperative analgesia are mandatory. The aim of this study was to assess the effect of adjuvants to ropivacaine on the duration of sensory and motor block. METHODS: In this double-blind randomized placebo-controlled study, we evaluated the analgesic effect of clonidine or dexamethasone (DXM) when added to ropivacaine for hallux valgus surgery. After obtaining institutional ethics research board approval and written informed consent, a total of 72 patients were randomly allocated. Fifty-seven of these patients were statistically analyzed. All patients received an ultrasound-guided single-shot popliteal fossa block with 30 mL of ropivacaine 0.75%, supplemented with saline, clonidine 100 µg, or DXM 5 mg. The primary end point was time to first pain sensation. Secondary end points were time to complete sensory and motor block regression. RESULTS: Compared to saline, duration to first pain sensation was prolonged by 9 hours (mean ± standard deviation: 31±9 hours) (42%) in the DXM group (P=0.024) and by 6 hours (28±10 hours) (27%) in the clonidine group (P=0.024). Compared to saline, DXM prolonged both complete sensory and motor blockade by 12 hours (25±7 hours) (46%) and 13 hours (36±6 hours) (55%), respectively, while clonidine prolonged complete sensory and motor blockade by 7 hours (30±7 hours) (27%) and 2 hours (22±5 hours) (10%), respectively. DXM prolonged sensory block regression time by 6 hours (21±7 hours) (41%) and clonidine by 2 hours (17±6 hours) (13%) compared to the control group (P=0.006). Similarly, DXM prolonged motor block regression by 7 hours (25±7 hours) (46%) and clonidine by 4 hours (21±4 hours) (19%) (P<0.0001). CONCLUSION: Addition of DXM and clonidine to ropivacaine significantly prolonged the duration of postoperative sensory and motor block. Dove Medical Press 2016-05-05 /pmc/articles/PMC4863693/ /pubmed/27226733 http://dx.doi.org/10.2147/LRA.S96073 Text en © 2016 Vermeylen et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Vermeylen, Kris
De Puydt, Joris
Engelen, Stefan
Roofthooft, Eva
Soetens, Filiep
Neyrinck, Arne
Van de Velde, Marc
A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
title A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
title_full A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
title_fullStr A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
title_full_unstemmed A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
title_short A double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
title_sort double-blind randomized controlled trial comparing dexamethasone and clonidine as adjuvants to a ropivacaine sciatic popliteal block for foot surgery
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863693/
https://www.ncbi.nlm.nih.gov/pubmed/27226733
http://dx.doi.org/10.2147/LRA.S96073
work_keys_str_mv AT vermeylenkris adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT depuydtjoris adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT engelenstefan adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT roofthoofteva adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT soetensfiliep adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT neyrinckarne adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT vandeveldemarc adoubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT vermeylenkris doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT depuydtjoris doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT engelenstefan doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT roofthoofteva doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT soetensfiliep doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT neyrinckarne doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery
AT vandeveldemarc doubleblindrandomizedcontrolledtrialcomparingdexamethasoneandclonidineasadjuvantstoaropivacainesciaticpoplitealblockforfootsurgery